Search Results - Milind Javle
- Showing 1 - 20 results of 85
- Go to Next Page
-
1
Molecular profiling of biliary tract cancer: a target rich disease by Apurva Jain, Milind Javle
Published 2016Revisão -
2
The role of PARP in DNA repair and its therapeutic exploitation by Milind Javle, Nicola J. Curtin
Published 2011Revisão -
3
Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma by Yun Shin Chun, Milind Javle
Published 2017Revisão -
4
Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer by Milind Javle, Elizabeth Smyth, Ian Chau
Published 2014Revisão -
5
Systemic therapy for gallbladder cancer by Milind Javle, Haitao Zhao, Ghassan K. Abou‐Alfa
Published 2019Revisão -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference by Gonzalo Sapisochín, Milind Javle, Jan Lerut, Masayuki Ohtsuka, R. Mark Ghobrial, Taizo Hibi, Nancy Man Kwan, Julie K. Heimbach
Published 2020Revisão -
14
-
15
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma by Reham Abdel‐Wahab, Gauri R. Varadhachary, Priya Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle
Published 2018Artigo -
16
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer by Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, Tove Buhl, Rune Smaaland, Herish Garresori, Milind Javle, Nils Glenjen, B.K. Abelseth, Bjørnar Gilje, Oddmund Nordgård
Published 2018Artigo -
17
Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance by Daniel H. Ahn, Milind Javle, Chul Ahn, Apurva Jain, Sameh Mikhail, Anne M. Noonan, Christina Wu, Rachna T. Shroff, James L. Chen, Tanios Bekaii‐Saab
Published 2016Artigo -
18
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma by Nawapol Kunkeaw, Sung Ho Jeon, K Lee, Betty H. Johnson, S. Tanasanvimon, Milind Javle, Chawalit Pairojkul, Yaovalux Chamgramol, Wipaporn Wongfieng, Bin Gong, Chanvit Leelayuwat, Y S Lee
Published 2012Artigo -
19
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study... by Pat Gulhati, Kanwal Raghav, Rachna T. Shroff, Gauri R. Varadhachary, Scott Kopetz, Milind Javle, Wei Qiao, Huamin Wang, Jeffrey S. Morris, Robert A. Wolff, Michael J. Overman
Published 2016Artigo -
20
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants by Milind Javle, Einat Shacham‐Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David R. Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan
Published 2021Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Oncology
Biology
Pancreatic cancer
Cancer research
Gastroenterology
Chemotherapy
Gene
Genetics
Colorectal cancer
Gemcitabine
Surgery
Mutation
Pathology
Adenocarcinoma
Breast cancer
Biochemistry
Clinical trial
Adverse effect
Cohort
Confidence interval
Radiation therapy
Clinical endpoint
Gallbladder cancer
Intrahepatic Cholangiocarcinoma
Receptor
Targeted therapy
CDKN2A